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Background: Mediastinal lymph node metastasis is one of the most 
principal prognostic factors in lung cancer treatment. N2 patients have 
a poor prognosis compared to N1, N0 cases. Histological diagnosis 
of mediastinal lymph node metastasis is necessary for the indication 
of surgery. There are several methods to examine the mediastinal 
lymphadenopathy, such as mediastinoscopy, endobronchial ultrasound- 
guided trans-bronchial needle aspiration (EBUS-TBNA) and etc. but it 
is neither practical nor clinically possible, however, to use mediastinos-
copy or EBUS for all patients with primary lung cancer. 
Methods: A prospective phase II study of indications for surgery, using 
video-assisted mediastinoscopy (VAM) and EBUS-TBNA to detect 
mediastinal lymph node metastasis was conducted in patients with 
resectable primary lung cancer of clinical stages I–IIIA. Indications 
for VAM were based on tumor size, CT ﬁndings and tumor markers, 
and patients were placed in group V ( VAM or EBUS) or group A ( 
thoracotomy without VAM) accordingly. EBUS-TBNA was performed 
if the CT ﬁndings showed mediastinal lymph nodes larger than 15 
mm in the shortest axis. Mediastinal lymph node involvement con-
ﬁrmed by VAM or EBUS was treated with chemotherapy followed by 
thoracotomy (group C) or radiotherapy (group D), and cases without 
detected metastasis underwent thoracotomy and systematic lymph node 
dissection (group B).
Group A patients had primary tumor resection and lymph node sam-
pling and group C patients, tumor resection and extended dissection of 
mediastinal lymph nodes via median sternotomy.
Results: Of the 500 eligible cases who were introduced to our center 
between Oct. 1998 and Des.2006, 249 underwent VAM (group V) 
and 217 had thoracotomy without VAM (group A). EBUS-TBNA was 
indicated for 34 patients. Of the VAM patients, 189 negative patients 
for metastasis received thoracotomy and 60 positive cases received 2 
courses of chemotherapy and 28 responders received thoracotomy and 
32 non-responders received radiation or best supportive care. Twelve 
negative cases by EBUS-TBNA received thoracotomy and 22 positive 
cases received chemotherapy. Six responders received thoracotomy and 
16 non-responders received radiation. The two- and 5- year survival 
rates of groups A, and B were 94.8%, and 90.0% (group A), and 90.8% 
and 59.1% (group B), respectively, while the 2-year rate in Group C 
was 68.0%.
Conclusions: We have demonstrated the usefulness of indication 
criteria for VAM and EBUS for the selection of candidates for primary 
lung cancer surgery. These indication criteria enabled us to avoid doing 
valueless examinations and to avoid unnecessary thoracotomy. The 
more favorable group A outcomes indicated both successful selection 
by these criteria of patients not requiring mediastinal examination, and 
superﬂuity of complete lymph node dissection, proper lymph nodes 
sampling being sufﬁcient for staging. 
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The plasma concentrations of several proteases of the clothing system 
have been shown to predicy prognosis in malignancy.This study is 
aimed to investigate the prognostic value of plasma levels of D-Dimer 
and other clothing system parameters in lung cancer.
Between 2004-2005 years, 100 new diagnosed lung cancer patients 
and and 25 healty person control groups were evaluated before treat-
ment. These patiens has’t a history of clothing system disorder or 
anticoaqulant therapy. Patients plasma D-Dimer and protrombine time, 
APTT, INR, biochemical parameters and blood count analysis were cal-
culated. Patients lung cancer stages, age, histology, thjerapy modalities 
( chemotherapy cycles, radiotherapy ), therapy results, survival times 
were determined. 
Multivariate statistical analysis was carried out using the Cox’s pro-
portional hazards model. Patients median age was 67; 86 were male. 
Patients stages were; 65 % local advanced, 35% advanced disease, 
(stage 4). Histologic gropus were; 72% nonsmall cell carsinoma, 28% 
small cell carsinoma. Patients median D-Dimer levels is 1250 mgr/dl 
that is signiﬁcantly higher than control groups. Survival times was 
signiﬁcantly higher in low D-Dimer patients( p(<)<0.05). The plasma 
levels of D-dimer predicted survival independently from the clinical 
stage of disease, histological type and performance status (HR=5,1; 
95% conﬁdence interval ). Plasma D-Dimer levels was signiﬁcantly 
higer in metastatic disease ( p<(<)0.01) .
As a result: These results suggest that plasma levels of D-dimer might 
be useful for predicting the clinical outcome in patients with lung can-
cer. However, further prospective studies are needed in a larger popula-
tion to conﬁrm about it and it’s cutt off point in malignansy.
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Purpose: It was well-known, that survival of lung cancer (LC) patients 
(LCP) with distant metastases (M1) takes several months. The search 
of markers for recognition of M1 was realized.
Methods: In trial (1986-2006) consecutive asimptomatic cases after 
surgery, monitored 242 LCP (males=204, females=38; age=57.4±8.9 
years; tumor size=4.6±2.3 cm; pneumonectomies=22, bi/lobec-
tomies=125, segmentectomies=54, exploratory thoracotomies and biop-
sies=41) with pathologic stage T1-4N0-3M0-1 (squamous=115, adeno-
carcinoma=97, large cell=30, T1=93, T2=67, T3=45, T4=37; N0=148, 
N1=5, N2=19; N3=70; G1=56, G2=69, G3=117; M0=147, M1=95) 
were reviewed. Variables selected for study were input levels of im-
munity blood parameters (IgG, IgM, IgA, natural antibodies, circulat-
ing immune complexes, percentage, absolute count and total population 
number of T-lymphocytes, B-cells, CD4, CD8, K-cells, CD1, CDw26, 
monocytes, CD4+2H, CD8+VV, CD4/CD8, leukocytes, lymphocytes, 
polymorphonuclear and sticknuclear leukocytes, NST-tests, indexes of 
stimulation of leukocytes (IS1-2), index of thymus function, phagocytic 
number, phagocyte index, index of complete phagocytosis), sex, age, 
TNMG. Representativeness of samplings was reached by means of 
randomization based on unrepeated random selection. Logistic regres-
sion, multi-factor clustering, discriminant analysis, structural equation 
modeling, Monte Carlo, bootstrap simulation and neural networks 
computing were used to determine any signiﬁcant overall regularity. 
Results: Logistic regression analysis displayed that detection of M1 
signiﬁcantly depended on: B-cells, K-cells, NST-spontaneous, IS2, 
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phagocytic number, ratio of B-cells and CD8+VV to LC cells. Neural 
networks computing, genetic algorithm selection and bootstrap simula-
tion revealed relationships between M1 and T-lymphocytes (rank=1), 
K-cells (2), ratio of segmented neutrophils to LC cells (3), B-cells (4), 
segmented neutrophils (5), CD4 (6), monocytes (7), ratio of leuco-
cytes to LC cells (8), phagocytic number (9), CD1 (10), eosinophils 
(11), CD8+VV (12), index of thymus function (13), lymphocytes (14), 
CDw26 (15), NST-spontaneous (16), CD4+2H (17), phagocyte index 
(18). It was discovered that recognition of LCP with distant metastases 
(T1-4N1-3M1; n=95) from LCP without distant metastases (T1-
4N0M0, n=147) signiﬁcantly depended on: 1) level of B-cell circuit; 
2) value of K-cell circuit; 3) level of humoral immunity; 4) neutrophils 
circuit; 5) value of cell ratio factors (ratio of LC cell population to im-
mune cell subpopulations in integral LCP organism); 6) LC charac-
teristics (T1-4, N0-3,G1-3, histology, tumor size); 7) anthropometric 
data (P=0.004). Correct classiﬁcation of LCP with M1 from LCP with 
M0 was 83.9% by logistic regression (odds ratio=25.3) and 100% by 
neural by neural networks computing (area under ROC curve=1.0; er-
rors=0.002).
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Obstruction within the lumen of the central airways that compromises 
ventilation and produces signiﬁcant symptoms could occur in patients 
with either primary lung cancer or endobronchial metastasis. Laser 
resection can be considered but it has limitation with resecting the mas-
sively obstructing mass because of smoke. Endobronchial cryotherapy 
is the therapeutic application of extreme cold for local destruction of 
living tissue. We underwent ﬂexible bronchoscopic cryotherapy for the 
patients with obstructive lung cancer with severe dyspnea.
Cases: A 69-year-old man was treated on the mechanical ventilator with 
respiratory failure. Computed tomography of the chest and bronchos-
copy showed the mass obstructing the main carina. He was performed 
the cryotherapy to remove the mass twice. Three days later, he could 
be weaned off the mechanical ventilator. The other 59-year-old man 
presented with severe dyspnea. Four years before, he underwent left 
pneumonectomy because of lung cancer. Bronchoscopy revealed that 
mass on the right main bronchus obstructed the lumen about 80%. He 
was also performed the cryotherapy to remove the endobronchial mass.
Conclusion: It is notable that ﬂexible bronchoscopic cryotherapy is 
not a painful procedure without general anesthesia and a very safe 
method without risk of perforation or massive bleeding. In conclusion, 
cryotherapy might be an excellent method for improving dyspnea and 
quality of life.
P1-020 Chest Medicine and Intervention Posters, Mon, Sept 3 
Incidental mediastinal tumors detected by screening with low dose 
chest CT
Lee, Hee Seok; Hwangbo, Bin; Lim, Kun Young; Lee, Soo Hyun; Kim, 
Hyae Young; Lee, Joo-Hyuk; Zo, Jae Ill 
National Cancer Center, Goyang-si, Korea
Background: As low dose chest CT (LDCT) is used frequently for 
the screening of lung cancer, incidental mediastinal tumors are found 
on LDCT images as by-products. We reviewed incidental mediastinal 
tumors detected by LDCT for the screening of lung cancer.
Methods: We retrospectively reviewed the radiologic reports of 11974 
subjects (M:F=6612:5362, mean (range)age 54 (40-92) years) who 
underwent LDCT for the screening of lung cancer between May 2001 
and Feb 2006. 
Result: We found 101 incidental mediastinal tumors in 100 subjects 
(0.84%) (M:F=61:39, mean (range) age 55 (40-79) years). The most 
frequent radiologic diagnosis was thymoma/thymic cyst (75, 74.2%), 
followed by pericardial cyst (7, 6.9%), neurogenic tumor (5, 5.0%), 
enteric cyst (3, 3.0%), bronchogenic cyst (2, 2.0%), intrathoracic goiter 
(2, 2.0%), and unspeciﬁed anterior mediastinal tumors (7, 6.9%). 
Out of 100 subjects, 11 (11.0%) underwent operation after detection 
by LDCT (median (range) size=35 (19-52) mm), 45 (45.0%) were 
followed up more than six months in our hospital (median (range) fol-
low-up time=19 (7-61) months)(median (range)size=13 (8-42) mm), 
and 44 (44.0%) were lost from our follow-up (median (range) size=16 
(4-38) mm). Among 46 tumors of 45 subjects who were followed up, 
38 tumors (82.6%) remained unchanged in size, 7 (15.2%) decreased 
and only one (2.2%) increased. 
Conclusion: Most of small mediastinal tumors that had been observed 
after detection by LDCT screening remained unchanged or decreased 
in size. For incidental mediastinal tumors detected by LDCT, short term 
follow-up using another CT may not be necessary. 
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Background and Objectives: Lung cancer is generally a disease of the 
elderly with more than 50% of lung cancer patients being diagnosed 
when they are over the age of 65, and approximately 30% of patients 
being diagnosed went they are over age 70. Elderly patients do not 
tolerate chemotherapy well compared with their younger counterparts 
because of the age-related progressive reduction in their condition. 
Hence, this study examined the inﬂuence of age, stage, type of cancer, 
and effectiveness of chemotherapy. 
Methods: This study reviewed the medical records of lung cancer 
patients who were diagnosed histopathologically at the Korea Uni-
versity Medical Center, Guro Hospital between 2000 and 2005. The 
patients’ age was grouped into the following two categories: <70 years, 
as non elderly; and ≥70 years as elderly patients. The survival time and 
response to chemotherapy in the elderly and non-elderly groups were 
compared.
Results: In NSCLC, the performance of the elderly patients was poorer 
than that of the non-elderly (p<0.001). There were signiﬁcant differ-
ences in the survival time between the elderly and non elderly who 
received treatment (NSCLC: 12 vs. 21 months, p<0.001; SCLC: 14 vs. 
28 months, p=0.04). However, in NSCLC and SCLC, elderly patients 
